GUASCHINO, Giulia
 Distribuzione geografica
Continente #
EU - Europa 162
NA - Nord America 142
AS - Asia 58
Totale 362
Nazione #
US - Stati Uniti d'America 141
IE - Irlanda 50
FR - Francia 27
DE - Germania 22
SE - Svezia 22
UA - Ucraina 17
IN - India 16
IT - Italia 15
HK - Hong Kong 12
CN - Cina 11
SG - Singapore 8
VN - Vietnam 6
FI - Finlandia 5
IR - Iran 4
PL - Polonia 3
CA - Canada 1
GB - Regno Unito 1
TR - Turchia 1
Totale 362
Città #
Dublin 50
Jacksonville 33
Chandler 27
Dearborn 12
Hong Kong 12
Dong Ket 6
Lawrence 6
Novara 6
Princeton 6
Beijing 5
Singapore 5
Wilmington 5
Kraków 3
Piemonte 3
Ann Arbor 2
Ashburn 2
Cadoneghe 2
Monmouth Junction 2
San Mateo 2
Ardabil 1
Baotou 1
Boardman 1
Bremen 1
Cento 1
Fairfield 1
Grafing 1
Hangzhou 1
Hefei 1
Helsinki 1
Kocaeli 1
Kunming 1
Leawood 1
Munich 1
Nanchang 1
Ottawa 1
Santa Clara 1
Torino 1
Zanjan 1
Zhengzhou 1
Totale 209
Nome #
Association between rheumatic diseases and cancer: results from a clinical practice cohort study 71
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study 66
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib 66
Inflammatory markers predict insulin sensitivity in active rheumatoid arthritis but not in psoriatic arthritis 66
Profiling the patients visiting the emergency room for musculoskeletal complaints: characteristics and outcomes 54
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 52
Totale 375
Categoria #
all - tutte 1.751
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.751


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202069 0 0 0 0 11 6 12 6 8 21 5 0
2020/202145 5 0 5 0 8 1 6 0 6 1 7 6
2021/202234 2 1 7 1 1 0 1 0 3 6 4 8
2022/2023125 12 6 12 0 7 14 3 8 52 1 7 3
2023/202449 1 13 7 1 6 0 6 2 0 0 6 7
2024/20253 1 0 2 0 0 0 0 0 0 0 0 0
Totale 375